The Child and Adolescent Thyroid Consortium (CATC) is an international research program dedicated to improving outcomes for children and adolescents with thyroid disease through collaborative efforts between centers around the world.

Together we can—and will—make a difference.

ExploreSubscribe

CATC by the Numbers

Participants
1,380

Participants

Institutions
21

Institutions

Countries
2

Countries

Accelerated Research
Accelerated Research
Large-scale collaboration through the CATC provides the necessary tools to accelerate translational research and precision medicine and achieve a healthier future for our patients.
Community
Community
CATC partners with non-profit organizations, disease-specific registries, patients, and families to spread awareness of and advance our initiatives.
Global Reach
Global Reach
Our pediatric thyroid community spans across the globe. By providing the infrastructure for large-scale research, CATC pioneers breakthroughs in pediatric thyroidology.

Recent Presentations

Presented on September 29, 2023
The Landscape of Childhood Differentiated Thyroid Carcinoma: An Inaugural CATC Study
American Thyroid Association Annual Meeting 2023
Wasserman, J. Isaza, A.

Presented on January 3, 2023
Child and Adolescent Thyroid Consortium Orientation
Children's Hospital of Philadelphia
Julia A. Baran and Kyle Hinkle

This presentation provides an overview of the onboarding process for the Registry and Biorepository for member institutions that have already ...
Presented on August 6, 2022
Child and Adolescent Thyroid Consortium: 2022 Updates
The 2022 Pediatric Thyroid Symposium at Seattle Children's Hospital
Andrew J. Bauer & Julia A. Baran

The Pediatric Thyroid Symposium is an annual conference held at Seattle Children's Hospital. The conference focuses on discussing guideline ...

Recent Publications

Published on August 13, 2024
Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy
Frontiers in Endocrinology
Julia Baran, Amber Isaza, Mya Bojarsky, Lama Alzoebie, Minkeun Song, Stephen Halada, Lindsay Sisko, Stephanie Gonzales, Sogol Mostoufi-Moab, and ...

Abstract Objective: Levothyroxine (LT4) monotherapy is the current recommended approach for treating pediatric patients post-total thyroidectomy (TT) based on ...
Published on August 2, 2024
Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection
European Thyroid Journal
Julia A Baran, Mya Bojarsky, Stephen Halada, Julio C Ricarte-Filho, Amber Isaza, Aime T Franco, Lea F Surrey, Tricia ...

Abstract Objective: The American Thyroid Association (ATA) Pediatric Guidelines recommend selective, prophylactic central neck dissection (pCND) for patients with papillary ...
Published on November 17, 2023
Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy
The Journal of Clinical Endocrinology & Metabolism
Mya Bojarsky, Julia A. Baran, Stephen Halada, Amber Isaza, Hongming Zhuang, Lisa States, Frederick D. Grant, Stephanie Robbins, Lindsay Sisko ...

Abstract Context: The American Thyroid Association (ATA) Pediatric Guidelines recommend patients not receive radioactive iodine therapy (RAIT) for differentiated thyroid ...